Global Forskolin Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. The Forskolin refers to an active compound derived from the roots of the Indian coleus (Coleus forskohlii), a tropical plant related to mint. The plant mainly grows in Nepal, India, and Thailand. Forskolin. Forskolin has application in treatment of obesity, glaucoma, allergies and asthma, heart failure, and intestinal spasms among others. The rising burden of cardiovascular diseases and increasing demand for dietary supplements as well as surging population of geriatric population are factors that are accelerating the global market demand. For instance, according to World Health Organization (WHO)- as of 2019, around 17.9 million people lost their lives due to cardiovascular diseases (CVDs), witnessing 32% of all global deaths. Furthermore, as per United Nations estimates - In 2019, there were around 703 million persons aged 65 years or over in the world. The number of older persons is projected to double to 1.5 billion in 2050. Also, growing prevalence of lifestyle diseases and increasing demand for natural dietary supplements are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, high cost and availability of substitute and side effects associated with consumption of forskolin impede the growth of the market over the forecast period of 2022-2028.
The key regions considered for the global Forskolin Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. Asia-Pacific is the leading region across the world in terms of market share owing to the growing prevalence of lifestyle diseases and wide availability of raw materials. Whereas, North America is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as increasing incidences of cardiovascular disease and growing demand for plant based health supplements in the region, would create lucrative growth prospects for the global Forskolin Market across the North America region.
Major market players included in this report are:
Nutra Green Biotechnology Co., Ltd.
Cymbio Pharma Pvt. Ltd.
Bioprex Labs
Sabinsa Corporation
Wolfson Berg Limited
Varion Lifesciences Pvt. Ltd.
Alchem International Limited
Flavour trove
Alexa Biotech Pvt. Ltd.
Shaanxi Jiahe Phytochem
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Concentration:
Low Concentration (10%)
Medium Concentration (20% to 40%)
High Concentration (95%)
By Application:
Allergy Treatment
Weight Management
Respiratory Problems
Cardiovascular Disorders
Glaucoma
Hypothyroidism
Psoriasis
Others
By End Use:
Nutraceuticals
Pharmaceutical
Dietary Supplements
Food Processing
Cosmetics
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Forskolin Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
